Last reviewed · How we verify

continuation of oxytocin administration

Assistance Publique - Hôpitaux de Paris · FDA-approved active Small molecule

Oxytocin is a peptide hormone that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown during labor and postpartum hemorrhage management.

Oxytocin is a peptide hormone that binds to oxytocin receptors to stimulate uterine contractions and promote milk letdown during labor and postpartum hemorrhage management. Used for Induction or augmentation of labor, Prevention and treatment of postpartum hemorrhage, Management of incomplete or inevitable abortion.

At a glance

Generic namecontinuation of oxytocin administration
SponsorAssistance Publique - Hôpitaux de Paris
Drug classPeptide hormone / Oxytocin receptor agonist
TargetOxytocin receptor (OXTR)
ModalitySmall molecule
Therapeutic areaObstetrics / Gynecology
PhaseFDA-approved

Mechanism of action

Oxytocin acts as an agonist at oxytocin receptors located on uterine smooth muscle and mammary gland myoepithelial cells. Upon receptor binding, it triggers calcium influx and increases intracellular calcium concentration, leading to sustained uterine contractions during labor and the postpartum period. It also facilitates milk ejection by contracting mammary tissue during lactation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results